Roger Anderson Presents BioQuest - A Diversified Search Group Company at LSI USA ‘23

BioQuest has pioneered and built one of the first specialty medical technology executive search firms in the U.S. and have been identifying, assessing, and placing outstanding executives for more than 30 years.
Speakers
Roger Anderson
Roger Anderson
Senior Advisor & Co-Founder, BioQuest

Transcription

Roger Anderson  0:02  

BioQuest is a retained executive search firm. And we've been focused on the life science sector for the last close to 40 years now. We operated as an independent company for 30 years. 33 years actually. And then, in 2016, we were introduced to Diversified search. And we had we really looked at, you know, where are we going to go with our practice and diversified search, after a lot of due diligence, we said was a perfect match for us, Diversified was a had a large practice in with hospital systems. And we were dealing with more and more venture capital firms that were in the, like Ascension, health care and provenance and things like that. We were dealing with because our focus is at the very senior level, and most of the marketing that we did were to the venture capital community. So diversified search, just really has developed a new model in our industry where they have, we were the first company they acquired and since then they've made five other acquisitions and the model being acquire firms that are really focused in their sector and have great brand names in their sector. And, and that's what the company has done over the last five, six years now. So it consists of these companies here, cybersecurity is alto associates, Grant Cooper's another one in the healthcare provider. Koya partners have very big acquisition made in the nonprofit sector, and then store back searches in higher education and yardstick. The latest is a management consulting company. So that's diversified search. These are the sectors that we within life sciences that we have a strong practice, about 50% of our business is with the medical device sector. Here we go. And then the biotechnology anything bio, another 25%, and diagnostics and digital health consists about 10%. And then speaking of the rolls, about 1/3 of our work is in and as you can see in the sea level, and we also do board work, which represents about 10 to 15% of our work. But then the key functional areas that are outlined here are pretty evenly split. We do a lot of work in in the clinical regulatory and quality areas, areas to which companies have a it's a very difficult sector to roll to find the kind of people you want. reimbursement is a big one now. So if I can advance this once again. So the other thing I've just like to toot our horn on is this big area of diversity diversified was founded by a woman 40 years ago and diversity has always been a big part of the search work that that we do. You can look at and read some of the data there. This is 2021 data and I'm sorry that we didn't have an update for 2022. But the portion of our placements that are woman are female and a people of color has really grown dramatically over the last let's say four years. So, if we really look at what is what is the the, the value proposition of using In the search firms and I'll say BioQuest and Diversified Search in particular, but one of the biggest things is, as young companies are growing, they're going through this various phases where they need to, let's say add a key leader. And the biggest thing I can say about what the value proposition we bring is we de risk the chance of a bad hire. And we we really optimize the whole search process. So thank you

 

LSI Europe ‘24 is filling fast. Secure your spot today to join Medtech and Healthtech leaders.

September 16-20, 2024 The Ritz-Carlton - Sintra, Portugal Register arrow